Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06198452 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vision Improvement for Patients With Age-Related Macular Degeneration

StatusNot Yet Recruiting
PhaseNot applicable
SponsorVIS, Inc.
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 31, 2025 to Dec 31, 2026
    • Start date: Jan 1, 2024 to Jan 1, 2025
    • Study completion date: Jun 30, 2026 to Jun 30, 2027
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
VIS, Inc.
4 trials monitored
See all monitored trials
This study is being conducted to assess the safety and efficacy of the VIS, LLC (VIS) Opti-K Low Vision Aid Device and treatment to provide vision improvement to patients with age-related macular degeneration.
Trial Details
NCT Number NCT06198452
Lead Sponsor VIS, Inc.
Conditions
(from sponsor)		 Macular Degeneration
Related terms Macular Degeneration
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov